Merrimack Pharmaceuticals MACK Stock
14.68 USD
{{ price }}
-0.339438%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
213.33M USD
LOW - HIGH [24H]
14.68
-
14.72 USD
VOLUME [24H]
109.53K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.08 USD
Merrimack Pharmaceuticals Price Chart
Merrimack Pharmaceuticals MACK Financial and Trading Overview
| Merrimack Pharmaceuticals stock price | 14.68 USD |
| Previous Close | 12.43 USD |
| Open | 12.42 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 12.3 - 12.52 USD |
| 52 Week Range | 3 - 13.66 USD |
| Volume | 134.5K USD |
| Avg. Volume | 76.55K USD |
| Market Cap | 176.68M USD |
| Beta (5Y Monthly) | 1.804929 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | December 13, 2019 |
| 1y Target Est | 4 USD |
MACK Valuation Measures
| Enterprise Value | 157.85M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.9606743 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 9.211896 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Merrimack Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.804929 |
| 52-Week Change | 98.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.66 USD |
| 52 Week Low | 3 USD |
| 50-Day Moving Average | 12.56 USD |
| 200-Day Moving Average | 9.97 USD |
MACK Share Statistics
| Avg. Volume (3 month) | 76.55K USD |
| Avg. Daily Volume (10-Days) | 60.6K USD |
| Shares Outstanding | 14.26M |
| Float | 10.36M |
| Short Ratio | 9.62 |
| % Held by Insiders | 1.20% |
| % Held by Institutions | 55.52% |
| Shares Short | 683.66K |
| Short % of Float | 6.60% |
| Short % of Shares Outstanding | 4.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1271:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -7.96% |
| Return on Equity (ttm) | -10.12% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1683000 USD |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.4M USD |
| Total Cash Per Share (mrq) | 1.36 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 42.393 |
| Book Value Per Share (mrq) | 1.345 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1744000 USD |
| Levered Free Cash Flow (ttm) | -1165375 USD |
Profile of Merrimack Pharmaceuticals
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | One Broadway |
| ZIP | 02142 |
| Phone | 617 720 8606 |
| Website | https://www.merrimack.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Q&A For Merrimack Pharmaceuticals Stock
What is a current MACK stock price?
Merrimack Pharmaceuticals MACK stock price today per share is 14.68 USD.
How to purchase Merrimack Pharmaceuticals stock?
You can buy MACK shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merrimack Pharmaceuticals?
The stock symbol or ticker of Merrimack Pharmaceuticals is MACK.
Which industry does the Merrimack Pharmaceuticals company belong to?
The Merrimack Pharmaceuticals industry is Biotechnology.
How many shares does Merrimack Pharmaceuticals have in circulation?
The max supply of Merrimack Pharmaceuticals shares is 14.53M.
What is Merrimack Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Merrimack Pharmaceuticals PE Ratio is now.
What was Merrimack Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Merrimack Pharmaceuticals EPS is -0.08 USD over the trailing 12 months.
Which sector does the Merrimack Pharmaceuticals company belong to?
The Merrimack Pharmaceuticals sector is Healthcare.
Merrimack Pharmaceuticals MACK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}